Louis Navellier is a prominent American investor, author, and financial analyst, best known for his quantitative approach to ...

For many, dividend investing is all about the yield. They search for stocks that offer high yields, thinking that’s enough to ...

Guggenheim analyst Vamil Divan lowered the firm’s price target on AbbVie (ABBV) to $212 from $221 and keeps a Buy rating on the shares. The ...

AbbVie Inc (NYSE:ABBV)., a leading biopharmaceutical company, stands at a critical juncture as it navigates the loss of ...

Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award a seed grant of $610,000 to Justus ...

Medtronic plc’s next-generation pill-sized camera saw its first use in a recent appointment, during which it captured thousands of high-definition images of the small bowel mucosa. The company hopes ...

AbbVie's strong financials and potential for cash flow make it a valuable investment, despite risks from patent expirations.